statistiche ricercatore

Continente	#
NA - Nord America	3.762
AS - Asia	512
EU - Europa	381
SA - Sud America	100
Continente sconosciuto - Info sul continente non disponibili	14
AF - Africa	12
OC - Oceania	2
Totale	4.783

Nazione	#
US - Stati Uniti d'America	3.729
SG - Singapore	161
CN - Cina	154
RU - Federazione Russa	117
IT - Italia	102
BR - Brasile	74
VN - Vietnam	49
FI - Finlandia	38
BD - Bangladesh	37
HK - Hong Kong	31
GB - Regno Unito	28
DE - Germania	23
CA - Canada	19
FR - Francia	16
IN - India	15
AE - Emirati Arabi Uniti	13
PL - Polonia	12
SE - Svezia	11
JP - Giappone	10
MX - Messico	9
NL - Olanda	9
CO - Colombia	7
IE - Irlanda	7
TR - Turchia	7
IQ - Iraq	6
ZA - Sudafrica	5
AR - Argentina	4
EC - Ecuador	4
ES - Italia	4
MY - Malesia	4
SA - Arabia Saudita	4
AT - Austria	3
BE - Belgio	3
CL - Cile	3
ID - Indonesia	3
IL - Israele	3
LT - Lituania	3
PY - Paraguay	3
CR - Costa Rica	2
EG - Egitto	2
ET - Etiopia	2
JM - Giamaica	2
NZ - Nuova Zelanda	2
PK - Pakistan	2
TH - Thailandia	2
TW - Taiwan	2
VE - Venezuela	2
XK - ???statistics.table.value.countryCode.XK???	2
AZ - Azerbaigian	1
BO - Bolivia	1
DZ - Algeria	1
GA - Gabon	1
GE - Georgia	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
MA - Marocco	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PT - Portogallo	1
QA - Qatar	1
RS - Serbia	1
SI - Slovenia	1
SX - ???statistics.table.value.countryCode.SX???	1
SY - Repubblica araba siriana	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	4.772

Nome	#
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology	1.585
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology	1.363
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology	898
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension	247
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry	246
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology	221
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry	90
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter Study	77
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry	56
Totale	4.783

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	6	0	0	0	0	0	0	0	0	0	4	1	1
2022/2023	23	1	2	2	1	3	1	0	5	1	0	7	0
2023/2024	55	1	2	8	2	3	4	3	0	1	1	16	14
2024/2025	3.442	1	1	14	3	19	18	40	72	33	1.564	1.212	465
2025/2026	1.180	70	146	106	106	97	83	139	54	123	86	73	97
2026/2027	77	41	36	0	0	0	0	0	0	0	0	0	0
Totale													4.783